[HTML][HTML] Long-lasting T cell responses in BNT162b2 COVID-19 mRNA vaccinees and COVID-19 convalescent patients

…, P Jalkanen, J Heroum, O Liedes, S Vara… - Frontiers in …, 2022 - frontiersin.org
The emergence of novel variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has made it more difficult to prevent the virus from spreading despite available …

[HTML][HTML] T cell immunity following COVID-19 vaccination in adult patients with primary antibody deficiency–a 22-month follow-up

…, M Marttila-Vaara, J Heroum, S Vara… - Frontiers in …, 2023 - frontiersin.org
Primary antibody deficiencies, such as common variable immunodeficiency (CVID), are
heterogenous disease entities consisting of primary hypogammaglobulinemia and impaired …

[HTML][HTML] Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose

M Belik, O Liedes, S Vara, A Haveri… - Frontiers in …, 2023 - frontiersin.org
Introduction The prime-boost COVID-19 mRNA vaccination strategy has proven to be effective
against severe COVID-19 disease and death. However, concerns have been raised due …

[HTML][HTML] High secondary attack rate and persistence of SARS-CoV-2 antibodies in household transmission study participants, Finland 2020–2021

…, O Liedes, H Nohynek, A Haveri, C Virta, S Vara… - Frontiers in …, 2022 - frontiersin.org
Background. Household transmission studies offer the opportunity to assess both secondary
attack rate (SAR) and persistence of SARS-CoV-2 antibodies over time. Methods. In Spring …

[HTML][HTML] Hybrid Immunity Improves the Immune Response after the Fourth COVID-19 Vaccine Dose in Individuals with Medical Conditions Predisposing to Severe …

…, A Juutinen, T Lehtonen, A Haveri, O Liedes, S Vara… - Vaccines, 2024 - mdpi.com
Data on immune responses following COVID-19 booster vaccinations and subsequent infections
in the immunocompromised are limited. We studied antibody responses after the fourth …

Impaired immunity and high attack rates caused by SARS‐CoV‐2 variants among vaccinated long‐term care facility residents

D Obach, A Solastie, O Liedes, S Vara… - Immunity …, 2022 - Wiley Online Library
Introduction Long‐term care facilities (LTCF) residents are at high risk for severe coronavirus
disease 2019 (COVID‐19), and therefore, COVID‐19 vaccinations were prioritized for …

[PDF][PDF] Vaccine-and infection-induced cellular immunity against SARS-CoV-2 in humans

S Vara - 2023 - helda.helsinki.fi
Vara developed a new PBMC stimulation method based on the old cell stimulation method…
Vara also performed PBMC stimulations and collected PBMC culture supernatants. Vara also …

Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose (preprint)

M Belik, O Liedes, S Vara, A Haveri, S Pöysti… - 2022 - pesquisa.bvsalud.org
The prime-boost COVID-19 mRNA vaccination strategy has proven to be effective against
severe COVID-19 disease and death. However, concerns have been raised due to decreasing …

T cell immunity to COVID-19 vaccines

EJ Wherry, DH Barouch - Science, 2022 - science.org
The development of multiple COVID-19 vaccines in record time is a major biomedical
achievement, but mechanistic immune correlates of vaccine protection remain to be determined. …

Neutralizing antibodies to SARS-CoV-2 Omicron variant after 3rd mRNA vaccination in health care workers and elderly subjects and response to a single dose in …

A Haveri, A Solastie, N Ekström, P Österlund… - MedRxiv, 2021 - medrxiv.org
The emergence of SARS-CoV-2 Omicron variant (B.1.1.529) with major spike protein
mutations has raised concern over potential neutralization escape and breakthrough infections …